Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 1 Indanone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108164408A reveals a novel FeCl3 catalyzed route for 7-halo-1-indanones offering improved regioselectivity and supply chain stability for pharmaceutical intermediates.
Patent CN101585758B introduces a novel trifluoromethanesulfonic acid mediated route for 5-hydroxy-1-indanone, offering superior scalability and cost efficiency for global supply chains.
Novel patent CN114890883A details a safe Mo(CO)6-based route to indanones, offering high yields and operational safety for reliable API intermediate supply chains.
Patent CN101597226B reveals a streamlined 2-step synthesis of 6-hydroxy-1-indanone from phenol, offering significant cost reduction and simplified supply chains for pharmaceutical manufacturing.
Patent CN101597226A reveals a novel TfOH-catalyzed cyclization route for 6-hydroxy-1-indanone, offering a streamlined alternative to traditional multi-step amino or methoxy precursor methods for cost-effective manufacturing.
Patent CN102417497A reveals a novel resolution method for Ramelteon intermediates, offering high optical purity and significant cost reduction in pharmaceutical manufacturing.
This novel chiral resolution method offers high purity and significant cost efficiency for global pharmaceutical intermediate manufacturing supply chains today.
Patent CN109293488B reveals a molten salt method for 5-chloroindanone, offering higher yields and safer processing for agrochemical and pharmaceutical intermediates.
Patent CN113248356A reveals a scalable two-step route for 4-hydroxy-1-indanone, offering cost reduction in pharmaceutical intermediate manufacturing via mild acid catalysis.
Novel chiral synthesis of Rasagiline Mesylate from 1-indanone. High yield, low cost, industrial scale-up ready for Parkinson's API intermediates.
Novel patent CN110627683A offers safe, high-purity 4-cyano-1-indanone synthesis. Eliminates toxic cyanating reagents for cost-effective pharmaceutical intermediate manufacturing.
Patent CN106588612A details ionic liquid catalysis for 5-chloro-1-indanone. Achieve high purity and cost reduction in agrochemical intermediate manufacturing with scalable solutions.
Patent CN112961086B details a novel Rh-catalyzed one-step synthesis of 2-methylene-1-indanone derivatives, offering significant cost reduction in API manufacturing and scalable production.
Patent CN108689815B details a novel copper-catalyzed method for indanone synthesis, offering significant cost reduction and green chemistry advantages for pharmaceutical manufacturing.
Novel aldol condensation method for Donepezil key intermediate using toluene solvent, offering high purity and yield for industrial scale-up.
Novel synthetic route for 5-chloro-1-indanone using 3-chlorobenzaldehyde. Reduces environmental pollution and simplifies scale-up for agrochemical intermediate manufacturing.
Novel patent CN106674011B reveals DMSO-based route for indanone derivatives offering reduced toxicity and enhanced supply chain reliability for global pharmaceutical manufacturers.
Patent CN101628889A reveals a high-yield toluene-based route for Donepezil key intermediates, offering significant cost and purity advantages for API manufacturers.
Novel Rh-catalyzed oxidative coupling method for 2-methylene-1-indanone derivatives. Offers high purity, simplified workflow, and cost-effective API intermediate manufacturing solutions.
Patent CN112961086A introduces a novel rhodium-catalyzed one-step synthesis method for high-purity pharmaceutical intermediates with significant cost reduction potential through streamlined manufacturing processes.